We invest in visionary science start-ups.

Our portfolio
Pitch your idea

We share our founders' passion for transformative technologies

We are

seed
investors.

Our roots are in

Austria.

We invest across

Europe.

20Portfolio
Companies

across life science, software and
hardware

We provide follow-on funding up to

€ 4m

In a nutshell

> 370

people work in
our portfolio
companies

Our current
fund is

€ 45m

Gateway to an
ecosystem
including high
tech facilities

> 30

nationalities

in our portfolio
companies.

We have strong ties to

leading edge
research

at the Institute of Science and
Technology, Austria

Our companies have raised

> € 200mn

in grants and equity funding.

Our starting point is a strong founding team with grit

We help you transition from a science project to a commercial venture.

About us

We focus on your needs.

We're here for you every step of the way, from negotiating university agreements to navigating corporate partnerships.

We let you focus on your needs.

Minimize distractions and let our expertise in finance, IP, grant acquisition, and HR help your business thrive.

We are transparent. Here is our term sheet.

Read our term sheet

We are scientists & investors. And a whole lot more.

Photo of our team

Bringing the two forces together is our mission. Our team’s unparalleled expertise in both science and business and our broad network turns ideas into reality.

Meet the team

Our Portfolio

Company in the Spotlight

By means of synthetic biology and genetic code expansion Valanx has developed a novel site-specific protein conjugation platform that allows precise control over conjugation site and number of conjugations on the protein of interest. Based on this platform Valanx is developing a number of cutting-edge biologics towards potential treatments for various indications.

Read more

News

MedTech company secures 7-figure early-stage funding from xista science ventures and Austria Wirtschaftsservice, to develop light stimulation based treatment for mental health disorders such as Major Depressive Disorder.

Read more

G.ST Antivirals reported positive results from Phase I clinical trials on its lead programme, a nasal spray containing 2-Deoxy-D-glucose. Phase II clinical trial funding round led by xista science ventures secured over EUR 6 million.

Read more

ONCO-Boost is a novel class of TLR4 immunostimulants that turn cold tumors into hot ones, increasing the efficacy of other therapies, notably immune-checkpoint inhibitors.

Read more

Swedish startup Rivus Batteries secures €0.5M from xista science ventures, NAVCAP AB, and EIT InnoEnergy to fast-track the deployment of its metal-free battery technology. The company aims to halve the cost and climate footprint of grid-scale energy storage by replacing heavy metal-based electrolytes with organic electrolytes in new flow batteries.

Read more

If there’s a breakthrough brewing in your brain, reach out to us.

Pitch your idea

Investment process

1. Share your Information

Use the form to tell us about your startup. Our team will review the details provided and will get back to you as soon as possible. If you meet the required criteria, we’ll plan together the next steps of your funding journey.

2. Start the financing process

We start by inviting you to a meeting and gather more information relevant to conducting a due diligence process, evaluating your business plans, growth strategy, and financial forecasts. Together, we analyze and determine the essential details and deal structure to meet your unique financing requirements.

3. Raise capital

If we invest, we will likely lead your funding round and will help you to fill your round and guide you through the process. From round preparations to execution, our team is here to support you, ensuring a smooth and successful experience.

4. Go beyond financing

We will be your partner in everything you encounter while executing your plans. We offer continuous support and guidance as we firmly believe long-term succes is a shared mission.